A new biological assay method for histamine-sensitizing factor using survival time as a response

Area of Science:

• Microbiology
• Immunology
• Pharmacology

Background:

• Pertussis bacilli produce a histamine-sensitizing factor (HSF).
• Accurate quantification of HSF is crucial for pertussis vaccine development and quality control.
• Existing assay methods may lack precision or sensitivity.

Purpose of the Study:

• To develop a novel, precise, and sensitive biological assay for quantifying the histamine-sensitizing factor of pertussis bacilli.
• To evaluate the assay's reproducibility and sensitivity.
• To investigate the influence of endotoxin on the assay for potential application in pertussis vaccine testing.

Main Methods:

• A biological assay was developed utilizing the survival time of mice as a graded response.
• Mice were subjected to a histamine challenge to assess the effect of HSF.
• The assay's precision, reproducibility, and sensitivity were validated.
• The impact of endotoxin on the assay was investigated.

Main Results:

• A new biological assay method was successfully developed.
• The assay demonstrated relative precision and reproducibility in HSF estimation.
• Validity tests confirmed the assay's sensitivity.
• The effect of endotoxin on the estimation was investigated, suggesting applicability for pertussis vaccine control.

Conclusions:

• The developed biological assay provides a precise and sensitive method for quantifying pertussis histamine-sensitizing factor.
• The assay's characteristics make it suitable for the quality control of pertussis vaccines.
• Further investigation into endotoxin's role supports its potential use in vaccine standardization.